150 related articles for article (PubMed ID: 35157784)
1. Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors.
Arkenau HT; Taylor D; Xu X; Chitnis S; Llacer-Perez C; Moore K; Nidamarthy PK; Ilankumaran P; De Vos-Geelen J
Clin Pharmacol Drug Dev; 2022 May; 11(5):585-596. PubMed ID: 35157784
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.
Lin WH; Feng HP; Shadle CR; O'Reilly T; Wagner JA; Butterton JR
Eur J Clin Pharmacol; 2014 Sep; 70(9):1107-13. PubMed ID: 24992979
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of sumatriptan when administered with norethindrone 1 mg/ethinyl estradiol 0.035 mg in healthy volunteers.
Moore KH; McNeal S; Britto MR; Bye C; Sale M; Richardson MS
Clin Ther; 2002 Nov; 24(11):1887-901. PubMed ID: 12501881
[TBL] [Abstract][Full Text] [Related]
4. Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/ethinylestradiol 35 microg in healthy subjects: an open-label, single-sequence, single-centre study.
Spence R; Mandagere A; Walker G; Dufton C; Boinpally R
Clin Drug Investig; 2010; 30(5):313-24. PubMed ID: 20384387
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women.
Sekar VJ; Lefebvre E; Guzman SS; Felicione E; De Pauw M; Vangeneugden T; Hoetelmans RM
Antivir Ther; 2008; 13(4):563-9. PubMed ID: 18672535
[TBL] [Abstract][Full Text] [Related]
6. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
7. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir.
Garg V; van Heeswijk R; Yang Y; Kauffman R; Smith F; Adda N
J Clin Pharmacol; 2012 Oct; 52(10):1574-83. PubMed ID: 22039291
[TBL] [Abstract][Full Text] [Related]
9. Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants.
Bhardwaj R; Stringfellow JC; Morris B; Croop RS; Bertz RJ
Headache; 2023 May; 63(5):652-662. PubMed ID: 37140071
[TBL] [Abstract][Full Text] [Related]
10. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
[TBL] [Abstract][Full Text] [Related]
11. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
12. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
Shoupe D
Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive.
Hofmann B; Reinecke I; Schuett B; Merz M; Zurth C
Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1059-70. PubMed ID: 25295716
[TBL] [Abstract][Full Text] [Related]
14. A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.
Ankrom W; Jackson Rudd D; Zhang S; Fillgrove KL; Gravesande KN; Matthews RP; Brimhall D; Stoch SA; Iwamoto MN
J Int AIDS Soc; 2021 Dec; 24(12):e25858. PubMed ID: 34935295
[TBL] [Abstract][Full Text] [Related]
15. Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.
Friedrich C; Port A; Ring A; Graefe-Mody U; Giessmann T; Iovino M; Woerle HJ
Clin Drug Investig; 2011; 31(9):643-53. PubMed ID: 21714581
[TBL] [Abstract][Full Text] [Related]
16. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
Shulman LP; Oleen-Burkey M; Willke RJ
Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
[TBL] [Abstract][Full Text] [Related]
17. Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.
Sivasubramanian R; Chakraborty A; Rouzade-Dominguez ML; Neelakantham S; Jakab A; Mensinga T; Legangneux E; Woessner R; Ufer M
Int J Clin Pharmacol Ther; 2015 Jul; 53(7):550-6. PubMed ID: 25943176
[TBL] [Abstract][Full Text] [Related]
18. Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Infante JR; Fecher LA; Falchook GS; Nallapareddy S; Gordon MS; Becerra C; DeMarini DJ; Cox DS; Xu Y; Morris SR; Peddareddigari VG; Le NT; Hart L; Bendell JC; Eckhardt G; Kurzrock R; Flaherty K; Burris HA; Messersmith WA
Lancet Oncol; 2012 Aug; 13(8):773-81. PubMed ID: 22805291
[TBL] [Abstract][Full Text] [Related]
19. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
[TBL] [Abstract][Full Text] [Related]
20. Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers.
Crauwels HM; van Heeswijk RP; Buelens A; Stevens M; Hoetelmans RM
Int J Clin Pharmacol Ther; 2014 Feb; 52(2):118-28. PubMed ID: 24161160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
